1.
Study on the Determination of Methimazole Residues with HPLC in Animal Foods;
高效液相色谱法测定动物源食品中甲巯咪唑残留的研究
2.
A HPLC method for determining metronidazole(MTZ),ronidazole (RNZ) and dimetridazole (DMZ) in chicken muscle was developed.
建立了测定鸡肉中二甲硝咪唑、罗硝唑、甲硝唑残留量的方法。
3.
A method of detecting mebendazole residue in eel muscles was established.
建立鳗鱼体内甲苯咪唑残留的分析方法。
4.
Study on the Determination of Mebendazole Residue in Aquatic Product;
水产品中甲苯咪唑残留量测定方法的研究
5.
Studies on Pharmacokinetics and Residues of Mebendazole in Carassius Auratus
甲苯咪唑在鲫鱼的药动学及残留消除研究
6.
Studies on Metabolism and Residue of Veterinary Mebendazole in Eel with Bath Treatment
甲苯咪唑在鳗鲡体内的药物代谢及组织残留
7.
Reevaluation of the Effects of Methimazole and Propylthiouracil in Patients with Graves Hyperthyrodism;
甲巯咪唑与丙硫氧嘧啶对Graves 甲亢疗效的再评价
8.
Syntheses and Coordination Properties of Bridged Bis(methimazole) Compounds
桥联双(甲巯咪唑)化合物的合成和配位性能
9.
Determination of thiamazole (TMZ) and its tablets by high-speed capillary electrophoresis with amperometric detection
高速毛细管电泳安培法检测甲巯咪唑及其制剂
10.
Synthesis of 2-Mercapto methyl benzimidazole
橡胶防老剂2-巯基甲基苯并咪唑的合成
11.
Studies on Acute Toxicity, Pharmacokinetics and Residues of Mebendazole in Carassius Auratus Gibelio
甲苯咪唑急性毒性及在异育银鲫体内药动学与残留研究
12.
Studies on Pharmacokinetics and Tissue Residues of Mebendazole and Its Metabolites in European Eels (Anguilla Anguilla)
甲苯咪唑及其代谢物在欧洲鳗鲡体内药物动力学及残留研究
13.
Determination of Mebendazole and Its Metabolites in Fishery by HPLC-UV
高效液相色谱法测定水产品中甲苯咪唑及其代谢物残留
14.
Simultaneous Determination of Mebendazole and Its Metabolites in Johnny Carp(Carassius Auratus Gibelio) Muscle by HPLC/UV Method
HPLC/UV法对银鲫肌肉组织中甲苯咪唑及其代谢产物残留的同时测定
15.
Determination of Mebendazole and Its Metabolites in Carassius auratus gibelio by HPLC-UV
银鲫肌肉中甲苯咪唑及其代谢物残留检测方法的建立—HPLC法
16.
Detection of Imazethapyr in Peanut
花生中咪唑乙烟酸残留量的测定方法
17.
The Effect of Methimazole on Experimental Autoimmune Thyroiditis;
甲巯咪唑对实验性自身免疫性甲状腺炎的干预研究
18.
Effects of Methimazole on Itopride Pharmacokinetics and Its Relationship with FMO3 Polymorphism in Vivo
甲巯咪唑对伊托必利药动学的影响及其与FMO3基因多态性的关系